Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
BIAF Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-4.70%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
BIAF Stock Analysis
BIAF
PE Ratio:
BIAF
PEG Ratio:
Not Available
BIAF
Forward EPS Growth (12 month):
0.00%
BIAF
PS Ratio:
1.3
BIAF
PSG Ratio:
Not Available
BIAF
Forward Revenue Growth (12 month):
0.00%
BIAF Articles
No data was found